Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2013 | 10-2012 | 07-2012 | 04-2012 | 01-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,557 | -5,144 | -3,587 | N/A | -13,098 |
| Depreciation Amortization | 111 | 74 | 37 | N/A | 166 |
| Accounts receivable | -2 | 198 | -168 | N/A | -342 |
| Other Working Capital | 97 | -674 | -82 | N/A | -817 |
| Other Operating Activity | 3,870 | 2,804 | 2,187 | 0 | 7,233 |
| Operating Cash Flow | $-3,481 | $-2,742 | $-1,613 | $N/A | $-6,858 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -13 | -13 | N/A | -11 |
| Purchase Sale Intangibles | -91 | -58 | -21 | N/A | -196 |
| Other Investing Activity | -91 | -58 | -21 | 0 | -196 |
| Investing Cash Flow | $-106 | $-71 | $-34 | $N/A | $-207 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 4,514 |
| Debt Issued | 103 | N/A | N/A | N/A | 838 |
| Debt Repayment | N/A | N/A | N/A | N/A | -8,000 |
| Common Stock Issued | N/A | 0 | N/A | N/A | 8,619 |
| Other Financing Activity | 2,433 | 2,444 | 2,458 | 0 | 3,423 |
| Financing Cash Flow | $2,536 | $2,444 | $2,458 | $N/A | $9,394 |
| Beginning Cash Position | 1,880 | 1,880 | 1,880 | N/A | 952 |
| End Cash Position | 829 | 1,512 | 2,691 | N/A | 3,282 |
| Net Cash Flow | $-1,051 | $-368 | $811 | $N/A | $2,330 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,481 | -2,742 | -1,613 | N/A | -6,858 |
| Capital Expenditure | -15 | -13 | -13 | N/A | -11 |
| Free Cash Flow | -3,496 | -2,755 | -1,626 | 0 | -6,869 |